<DOC>
	<DOCNO>NCT00391664</DOCNO>
	<brief_summary>The purpose study evaluate quality life long-term gynecologic cancer survivor .</brief_summary>
	<brief_title>Questionnaire Study Gynecological Cancer Survivors</brief_title>
	<detailed_description>Since early 1970s , death rate major gynecological tumor significantly decline , reduction 42 % endometrial , 49 % cervix , 27 % vagina vulva , 11 % ovarian cancer . Thus , approximately 82,000 new gynecologic case year , woman live , necessarily force cope psychological behavioral morbidity . Psychosocial data cancer patient portray significant fear anxiety diagnosis treatment potential high level psychological sexual morbidity . While many study do investigate sexual outcome , little data available basic domain quality life , i.e . emotional social adjustment , occupational outcome , aspect physical health might influence quality life gynecologic cancer survivor . There need basic descriptive research area , particularly investigation include representative sample differ socioeconomic racial/ethnic group . The goal propose study evaluate quality life long-term gynecologic cancer survivor . The specific aim : 1 . Describe quality life ( mental health physical functioning component ) , stress , sexual functioning among survivor gynecologic malignancy 2 . Describe difference disease site group ( i.e . cervical , endometrial , ovarian , vulva ) . It show cancer group improvement mood cop achieve brief , cost effective intervention ( e.g . ten therapy hour delivery group format ) . These multi-modal intervention stress reduction , disease/treatment information , cognitive behavioral coping strategy , social support . There suggestive evidence disease specific intervention , include sexual therapy gynecologic patient , result improvement well . Research focus issue aid availability reliable valid strategy assess quality life ( SF-36 ; FACT ) sexuality . Before clinical trial undertaken , research must provide comprehensive assessment quality life gynecologic cancer survivor .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Genital Neoplasms , Female</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<criteria>Female participant diagnose gynecologic cancer Participants age 20 75 year old , inclusive Participants previously treat stage ( IIV ) follow cancer : cervix ; endometrium ; ovary ; vulva ; vagina ; genital cancer Participants receive treatment primary cancer past 210 year Male participant Participants major psychosis ( e.g . organic brain syndrome ; schizophrenia ; bipolar disorder ; mental retardation ) . Participants significant hear deficit Participants prior nongynecologic cancer diagnosis Participants refuse form cancer treatment , whether standard care experimental . Participants deficient ability read/speak English Participants reside &gt; 90 mile research site Participants diagnose dementia Participants diagnose pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Endometrial cancer</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Cervical Cancer</keyword>
	<keyword>Genital Cancer</keyword>
	<keyword>Vulvar Cancer</keyword>
	<keyword>Vaginal Cancer</keyword>
	<keyword>Other Gynecological Cancers</keyword>
</DOC>